Published in Eur J Immunol on December 01, 1997
Cytokines in asthma. Thorax (1999) 2.64
Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset. Thorax (2012) 2.14
Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest (1999) 2.05
Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med (2002) 2.04
CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest (2002) 1.73
Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov (2013) 1.47
Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol (1999) 1.33
Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res (2001) 1.31
Airway smooth muscle as an immunomodulatory cell. Pulm Pharmacol Ther (2008) 1.20
Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. J Clin Invest (2005) 1.20
Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol (1998) 1.11
Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunology (2003) 1.06
Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1beta and TNFalpha: effects of IL-10 and corticosteroids. Br J Pharmacol (1999) 1.05
Chemokines in allergic lung inflammation. Immunology (2002) 1.04
Chemokines and their receptors as potential targets for the treatment of asthma. Br J Pharmacol (2007) 1.01
Chemokines and chemokine receptors: their role in allergic airway disease. J Clin Immunol (1999) 0.95
Rosmarinic acid as a downstream inhibitor of IKK-beta in TNF-alpha-induced upregulation of CCL11 and CCR3. Br J Pharmacol (2006) 0.93
Chemokines in the limbal form of vernal keratoconjunctivitis. Br J Ophthalmol (2000) 0.90
Biologic therapies targeting eosinophils: current status and future prospects. J Allergy Clin Immunol Pract (2015) 0.90
Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin. Br J Dermatol (2014) 0.87
Allergen-induced, eotaxin-rich, proangiogenic bone marrow progenitors: a blood-borne cellular envoy for lung eosinophilia. J Allergy Clin Immunol (2010) 0.86
Apoptosis and the airway epithelium. J Allergy (Cairo) (2011) 0.85
Chronic aeroallergen during infancy enhances eotaxin-3 expression in airway epithelium and nerves. Am J Respir Cell Mol Biol (2005) 0.84
House dust mite allergy: environment evaluation and disease prevention. Asia Pac Allergy (2014) 0.83
Local proliferation and mobilization of CCR3(+) CD34(+) eosinophil-lineage-committed cells in the lung. Immunology (2010) 0.83
The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation. Pediatr Allergy Immunol (2010) 0.83
Transforming growth factor-β stimulates the expression of eotaxin/CC chemokine ligand 11 and its promoter activity through binding site for nuclear factor-κβ in airway smooth muscle cells. Clin Exp Allergy (2010) 0.82
The function of CCR3 on mouse bone marrow-derived mast cells in vitro. Immunology (2010) 0.82
Wogonin, a plant flavone from Scutellariae radix, attenuated ovalbumin-induced airway inflammation in mouse model of asthma via the suppression of IL-4/STAT6 signaling. J Clin Biochem Nutr (2015) 0.82
Selective regulation of MAP kinases and chemokine expression after ligation of ICAM-1 on human airway epithelial cells. Respir Res (2006) 0.81
Chemokines and their role in airway hyper-reactivity. Respir Res (2000) 0.81
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients. Respir Res (2010) 0.81
Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. Ther Adv Chronic Dis (2016) 0.81
Directional secretory response of double stranded RNA-induced thymic stromal lymphopoetin (TSLP) and CCL11/eotaxin-1 in human asthmatic airways. PLoS One (2014) 0.81
Expression of IL-4/IL-13 receptors in differentiating human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2010) 0.80
Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies. Mediators Inflamm (2003) 0.80
Human leukocyte antigen-G expression in differentiated human airway epithelial cells: lack of modulation by Th2-associated cytokines. Respir Res (2013) 0.79
Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells. PLoS One (2012) 0.79
Gene-Gene Interaction Between CCR3 and Eotaxin Genes: The Relationship With Blood Eosinophilia in Asthma. Allergy Asthma Immunol Res (2013) 0.78
Human eotaxin induces eosinophil extravasation through rat mesenteric venules: role of alpha4 integrins and vascular cell adhesion molecule-1. Immunology (1999) 0.78
Comprehensive multiplexed protein quantitation delineates eosinophilic and neutrophilic experimental asthma. BMC Pulm Med (2014) 0.78
Simvastatin Inhibits IL-5-Induced Chemotaxis and CCR3 Expression of HL-60-Derived and Human Primary Eosinophils. PLoS One (2016) 0.78
Eotaxin and asthma: some answers, more questions. Clin Exp Immunol (1999) 0.78
Mixture of Polyphenols and Anthocyanins from Vaccinium uliginosum L. Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice. Evid Based Complement Alternat Med (2012) 0.78
Inhibitory effect of CCR3 signal on alkali-induced corneal neovascularization. Int J Ophthalmol (2012) 0.78
Experimental advances in understanding allergic airway inflammation. Front Biosci (Schol Ed) (2013) 0.77
Arsenic trioxide alleviates airway hyperresponsiveness and eosinophilia in a murine model of asthma. Cell Mol Immunol (2010) 0.77
The translational repressor T-cell intracellular antigen-1 (TIA-1) is a key modulator of Th2 and Th17 responses driving pulmonary inflammation induced by exposure to house dust mite. Immunol Lett (2012) 0.77
Increased CCL24/eotaxin-2 with postnatal ozone exposure in allergen-sensitized infant monkeys is not associated with recruitment of eosinophils to airway mucosa. Toxicol Appl Pharmacol (2011) 0.77
Efficacy of Astaxanthin for the Treatment of Atopic Dermatitis in a Murine Model. PLoS One (2016) 0.77
Kinetics of change in the eotaxin concentration in serum and cerebrospinal fluid of mice infected with Angiostrongylus cantonensis. Parasitol Res (2003) 0.76
The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD). Respir Res (2017) 0.75
Eotaxin expression in Sephadex-induced lung injury in rats. Am J Pathol (1999) 0.75
Eotaxin-Rich Proangiogenic Hematopoietic Progenitor Cells and CCR3+ Endothelium in the Atopic Asthmatic Response. J Immunol (2016) 0.75
Characterization of chemokine CCR3 agonist-mediated eosinophil recruitment in the Brown-Norway rat. Br J Pharmacol (1999) 0.75
Serum IL-17 & eotaxin levels in asthmatic patients with allergic rhinitis. Pak J Med Sci (2016) 0.75
Antileukotriene reverts the early effects of inflammatory response of distal parenchyma in experimental chronic allergic inflammation. Biomed Res Int (2013) 0.75
An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis. Inflammation (2016) 0.75
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell (1996) 17.13
Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell (1991) 13.69
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med (1992) 11.90
Resolution of the early placental mammal radiation using Bayesian phylogenetics. Science (2001) 8.68
The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics. J Infect Dis (1980) 8.40
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci U S A (1997) 8.27
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med (1998) 7.24
Protein methylation in behavioural control mechanisms and in signal transduction. Nature (1979) 6.87
Sensory transduction in Escherichia coli: two complementary pathways of information processing that involve methylated proteins. Proc Natl Acad Sci U S A (1977) 6.63
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest (1998) 6.51
T-cell function and migration. Two sides of the same coin. N Engl J Med (2000) 6.47
Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature (1981) 6.36
Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature (1973) 6.34
Calcitonin gene-related peptide is a potent vasodilator. Nature (1985) 6.13
CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature (1997) 5.45
CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med (1997) 5.18
Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science (1997) 4.89
The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol (2000) 4.78
Breast cancer: management of the opposite breast. Oncology (Williston Park) (1988) 4.71
Parallel adaptive radiations in two major clades of placental mammals. Nature (2001) 4.65
The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature (1999) 4.55
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol (1998) 4.51
Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med (1994) 4.36
Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today (1998) 4.21
Role of prostaglandin-mediated vasodilatation in inflammation. Nature (1977) 3.95
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med (1972) 3.93
Sensory transduction in Escherichia coli: role of a protein methylation reaction in sensory adaptation. Proc Natl Acad Sci U S A (1977) 3.93
Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest (1991) 3.88
Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest (1996) 3.74
Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis (1990) 3.70
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70
Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Biochem Pharmacol (1968) 3.62
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med (1995) 3.61
Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol (1979) 3.58
The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J Immunol (1971) 3.51
Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med (1997) 3.48
Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis (1988) 3.45
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med (1996) 3.33
Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol (1997) 3.24
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest (1999) 3.21
How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer. J Pers Soc Psychol (1993) 3.18
Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J Virol (1992) 3.16
Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci U S A (1989) 3.13
Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes. Clin Exp Immunol (1970) 3.09
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.06
Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis (1989) 3.06
Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol (2000) 3.05
Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J (2004) 3.04
Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS (2000) 2.99
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 2.90
Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol (1991) 2.88
Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med (1995) 2.83
Failure of sensory adaptation in bacterial mutants that are defective in a protein methylation reaction. Cell (1978) 2.81
Increased incidence of congenital malformations in children with transient thyroid-stimulating hormone elevation on neonatal screening. J Pediatr (1998) 2.80
Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. J Virol (1993) 2.70
Lung volume reduction surgery for emphysema. Med J Aust (1997) 2.70
Standards for practical allergen-specific immunotherapy. Allergy (2006) 2.70
Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest (1997) 2.68
An eosinophil leukocyte chemotactic factor of anaphylaxis. J Exp Med (1971) 2.65
Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med (1996) 2.64
Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun (1995) 2.55
HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5. J Biol Chem (1997) 2.55
Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy (2005) 2.55
BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science (1999) 2.54
Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature (1988) 2.54
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
Breast feeding in Scotland. BMJ (1994) 2.49
Molecular evidence for multiple origins of Insectivora and for a new order of endemic African insectivore mammals. Proc Natl Acad Sci U S A (1998) 2.44
Surface antigens, SBU-T4 and SBU-T8, of sheep T lymphocyte subsets defined by monoclonal antibodies. Immunology (1985) 2.40
Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial. Lancet (2001) 2.39
Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J Virol (1998) 2.38
Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol (1985) 2.38
Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS. Am J Pathol (1991) 2.38
Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet (2002) 2.38
Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ (1991) 2.32
T cells and eosinophils in the pathogenesis of asthma. Immunol Today (1992) 2.30
Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol (1997) 2.28
Characterization of two sheep lymphocyte differentiation antigens, SBU-T1 and SBU-T6. Immunology (1985) 2.18
CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis (1990) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Role of methionine in bacterial chemotaxis: requirement for tumbling and involvement in information processing. Proc Natl Acad Sci U S A (1975) 2.16
Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin Allergy (1985) 2.15
Studies on eosinophil leucocyte migration. I. Eosinophil and neutrophil accumulation following antigen-antibody reactions in guinea-pig skin. Clin Exp Immunol (1970) 2.13
Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J Exp Med (1981) 2.12
TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem (2000) 2.11
Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol (1993) 2.11
High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest (1997) 2.09
Pleiotropic aspartate taxis and serine taxis mutants of Escherichia coli. J Gen Microbiol (1979) 2.08
Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells. J Cell Biol (1996) 2.07
Adhesion of a human fecal Escherichia coli strain to mouse colonic mucus. Infect Immun (1985) 2.07